SALT INTAKE AND HYPERTENSIVE RENAL INJURY IN AFRICAN-AMERICANS - A THERAPEUTIC PERSPECTIVE

被引:23
作者
WEIR, MR
机构
[1] Division of Nephrology and Clinical Research Unit, Department of Medicine, University of Maryland Hospital, Baltimore, MD
关键词
HYPERTENSIVE RENAL INJURY; AFRICAN-AMERICANS; DIETARY SALT CONSUMPTION; BLOOD PRESSURE;
D O I
10.1016/0895-7061(95)00048-T
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertensive renal injury is a major identifiable cause of end-stage renal disease in African-Americans. A complex nexus of sociologic, biologic, environmental, and sociocultural variables are involved in mediating this risk and interrelate with dietary salt consumption and salt sensitivity. It is likely that dietary salt intake and salt sensitivity are linked in influencing the risk of hypertensive renal injury, since it has been demonstrated that increasing dietary salt in salt-sensitive patients such as African-Americans results in an increase in glomerular filtration fraction and proteinuria. Dietary salt likely influences both carbohydrate metabolism and blood pressure, either directly or through its influence on other ions such as calcium or potassium. The interrelationship between salt and pharmacologic interventions is an important clinical issue, since the efficacy of these therapies is influenced by the amount of salt in the diet. It is also likely that the changes in blood pressure and carbohydrate metabolism induced by greater dietary salt intake may be more specifically corrected by some nonpharmacologic or pharmacologic interventions compared to others. Since dietary salt has identifiable influences on blood pressure, renal hemodynamics, and carbohydrate metabolism, its overall effect on cardiovascular risk, particularly in high-risk groups such as African-Americans, assumes increasing importance.
引用
收藏
页码:635 / 644
页数:10
相关论文
共 78 条
[51]  
Bakris G.L., Wilson D.M., Burnett J.C., The renal, forearm, and hormonal responses to standing in the presence and absence of propranolol, Circulation, 74, pp. 1661-1065, (1986)
[52]  
Epstein M., Oster J.R., Beta blockers and the kidney, Min Electrolyte Metab, 8, pp. 237-254, (1982)
[53]  
Saunders E., Weir M.R., Kong B.W., Et al., A comparison of the efficacy and safety of a beta-blocker, calcium channel blocker, and converting enzyme inhibitor in hypertensive blacks, Arch Int Med, 150, pp. 1707-1713, (1990)
[54]  
Anderson S., Rennke H.G., Brenner B.M., Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat, J Clin Invest, 77, pp. 1993-2000, (1986)
[55]  
Harris D.C.H., Chan L., Schrier R.W., Remnant kidney hypermetabolism and progression of chronic renal failure, Am J Physiol, 23, pp. F267-F276, (1988)
[56]  
Bauer J.H., Role of angiotensin converting enzyme inhibitors in essential and renal hypertension: Effects of Captopril and enalapril on renin-angiotensin-aldosterone, renal function, and hemodynamics, salt and water excretion and body fluid composition, Am J Med, 77, pp. 43-51, (1984)
[57]  
Sowers J.R., Zemel M.B., Zemel P., Et al., Salt sensitivity in blacks. Salt intake and natriuretic substances, Hypertension, 12, pp. 485-490, (1988)
[58]  
Levy S.B., Lilley J.J., Frigon R.P., Stone R.A., Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake, J Clin Invest, 60, pp. 129-138, (1977)
[59]  
Kirschenbaum M.A., Stein J.H., The effect of inhibition of prostaglandin synthesis on urinary sodium excretion in the conscious dog, J Clin Invest, 57, pp. 517-521, (1970)
[60]  
Saunders P.W., L-Arginine and nitric oxide in saltsensitive hypertension (Abst), Hypertension, 6A, (1994)